Anti-Amyloid Therapies for Alzheimer’s Disease: An Alzheimer Europe Position Paper and Call to Action
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Anti-Amyloid Therapies for Alzheimer’s Disease: An Alzheimer Europe Position Paper and Call to Action ; volume:11 ; number:2 ; day:10 ; month:2 ; year:2024 ; pages:265-273 ; date:3.2024
The journal of prevention of Alzheimer's disease ; 11, Heft 2 (10.2.2024), 265-273, 3.2024
- Creator
-
Bradshaw, Angela C.
Georges, J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2024.37
- URN
-
urn:nbn:de:101:1-2404260705308.590404085829
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bradshaw, Angela C.
- Georges, J.
- SpringerLink (Online service)
Other Objects (12)
Alzheimer’s disease hypothesis and related therapies
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Amyloid PET imaging: applications beyond Alzheimer’s disease
Non-drug Therapies for Alzheimer’s Disease: A Review
The Development of Pharmacological Therapies for Alzheimer’s Disease
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer’s Disease in Japan
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Alzheimer’s disease hypothesis and related therapies
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Amyloid PET imaging: applications beyond Alzheimer’s disease
Non-drug Therapies for Alzheimer’s Disease: A Review
The Development of Pharmacological Therapies for Alzheimer’s Disease
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer’s Disease in Japan
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Alzheimer’s disease hypothesis and related therapies
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Amyloid PET imaging: applications beyond Alzheimer’s disease
Non-drug Therapies for Alzheimer’s Disease: A Review
The Development of Pharmacological Therapies for Alzheimer’s Disease
Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer’s Disease in Japan
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease